Figures & data
Figure 1 Diagram of coronal sections from − 7.3 to − 7.8 mm posterior to bregma through the rat brain, showing the microinjection sites in the DRN (indicated by dots) (Paxinos & Watson, Citation1986).
![Figure 1 Diagram of coronal sections from − 7.3 to − 7.8 mm posterior to bregma through the rat brain, showing the microinjection sites in the DRN (indicated by dots) (Paxinos & Watson, Citation1986).](/cms/asset/4520118c-4c51-4ee2-acf6-c0e6f76b50ce/iphb_a_221218_f0001_b.gif)
Figure 2 Mean (± SEM) of immobility time in the FST (A) and locomotor activity in the OFT (B) of HE from Kielmeyera coriacea. (Kc; 60.0 mg/kg), fluoxetine (FLUO; 10.0 mg/kg) or nortriptyline (NOR; 15.0 mg/kg) compared with control treated rats (C; 0.9% NaCl). All treatments were applied chronically by gavage. Dunnett's test revealed significant differences, *p < 0.05, (n = 7 to 10).
![Figure 2 Mean (± SEM) of immobility time in the FST (A) and locomotor activity in the OFT (B) of HE from Kielmeyera coriacea. (Kc; 60.0 mg/kg), fluoxetine (FLUO; 10.0 mg/kg) or nortriptyline (NOR; 15.0 mg/kg) compared with control treated rats (C; 0.9% NaCl). All treatments were applied chronically by gavage. Dunnett's test revealed significant differences, *p < 0.05, (n = 7 to 10).](/cms/asset/16113a23-6ccd-4b2f-b777-e883caabcf14/iphb_a_221218_f0002_b.gif)
Figure 3 Mean ± SD of HE from Kielmeyera coriacea. on [3H]5-HT, [3H]NA, and [3H]DA uptake in rat brain cortex or striatum synaptosomes (three independent experiments, each performed in triplicate). Dunnett's test showed treatments effects *p < 0.05 and **p < 0.01 compared with the control group.
![Figure 3 Mean ± SD of HE from Kielmeyera coriacea. on [3H]5-HT, [3H]NA, and [3H]DA uptake in rat brain cortex or striatum synaptosomes (three independent experiments, each performed in triplicate). Dunnett's test showed treatments effects *p < 0.05 and **p < 0.01 compared with the control group.](/cms/asset/8cb35a97-b4de-468a-ab67-2b8d03e3f501/iphb_a_221218_f0003_b.gif)
Figure 4 Mean (± SEM) of immobility time in FST for intra-DRN 5-HT (5.0, 10.0, and 20.0 nmol) (A) or 8-OHDPAT (0.3, 0.6, and 1.0 nmol) (B) compared with control group (C; intra-DRN vehicle-saline + 1% ascorbic acid) in chronically treated rats (gavage). Dunnett's test showed treatment effects *p < 0.05 compared with the control group (n = 7 to 10).
![Figure 4 Mean (± SEM) of immobility time in FST for intra-DRN 5-HT (5.0, 10.0, and 20.0 nmol) (A) or 8-OHDPAT (0.3, 0.6, and 1.0 nmol) (B) compared with control group (C; intra-DRN vehicle-saline + 1% ascorbic acid) in chronically treated rats (gavage). Dunnett's test showed treatment effects *p < 0.05 compared with the control group (n = 7 to 10).](/cms/asset/77ea0a06-fbbb-4e1c-a74c-3eeb2bb38f9e/iphb_a_221218_f0004_b.gif)
Figure 5 Mean (± SEM) of immobility time in the FST of intra-DRN vehicle (saline + 1% ascorbic acid), 5-HT (5.0 nmol), or 8-OHDPAT (0.6 or 1.0 nmol) in rats chronically treated (gavage) with saline or HE from Kielmeyera coriacea. (Kc; 60.0 mg/kg). Dunnett's test showed significant effects *p < 0.05 and **p < 0.01 compared with the control group (C, V + S, intra-DRN vehicle + saline by gavage) (n = 7 to 9).
![Figure 5 Mean (± SEM) of immobility time in the FST of intra-DRN vehicle (saline + 1% ascorbic acid), 5-HT (5.0 nmol), or 8-OHDPAT (0.6 or 1.0 nmol) in rats chronically treated (gavage) with saline or HE from Kielmeyera coriacea. (Kc; 60.0 mg/kg). Dunnett's test showed significant effects *p < 0.05 and **p < 0.01 compared with the control group (C, V + S, intra-DRN vehicle + saline by gavage) (n = 7 to 9).](/cms/asset/7a164dff-875c-4e39-a774-7cec9b82366b/iphb_a_221218_f0005_b.gif)